Belluscura plc announced that Robert ("Bob") Fary has joined the Company as Senior Vice President of Global Sales. Bob has thirty-years of experience in the respiratory industry where he has held leadership roles at major oxygen concentrator manufacturers and durable medical equipment companies. During the past two decades, Bob's industry leading team was directly responsible or contributed to the sale of over 1 million portable oxygen concentrators, generating revenues in excess of $1 billion.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 GBX | +8.33% | -3.70% | -43.48% |
05-22 | AIM WINNERS & LOSERS: Zenova scores NHS deal; Staffline "encouraged" | AN |
04-02 | Belluscura sees financial hit from delay to closing TMT acquisition | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.48% | 25.19M | |
-3.87% | 184B | |
-0.52% | 107B | |
-3.65% | 67.9B | |
-5.79% | 46.49B | |
+13.26% | 45.81B | |
+6.38% | 42.55B | |
+18.83% | 30.78B | |
+16.53% | 26.11B | |
-6.80% | 23.9B |
- Stock Market
- Equities
- BELL Stock
- News Belluscura plc
- Belluscura plc Appoints Robert ("Bob") Fary as Senior VP of Global Sales